Bioxytran Inc. $BIXT Dr. David Platt, CEO of newly formed company Bioxytran Inc, a developmental stage biotechnology company, recently addressed his shareholders in a letter discussing the significant progress the organization has made as of late. In said letter, Platt touched on a variety of matters, including a significant company milestone; Bioxytran, Inc’s transition from a privately held, to fully reporting public company under the new stock symbol BIXT.
https://finance.yahoo.com/news/bioxytran-inc-...00799.html